RESEARCH TRIANGLE PARK, N.C. and SAN FRANCISCO, May 22, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (GTHX) (Nasdaq: GTHX), a commercial-stage oncology company, and Deimos Biosciences, a portfolio ...
RESEARCH TRIANGLE PARK, N.C. and CAMBRIDGE, Mass., July 22, 2020 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced a license agreement for ...
G1 Therapeutics and Pepper Bio Announce Global (Excluding Asia-Pac) License Agreement for Lerociclib
RESEARCH TRIANGLE PARK, N.C. and BOSTON, May 01, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (GTHX) (Nasdaq: GTHX), a commercial-stage oncology company, and Pepper Bio, the world’s first transomics ...
RESEARCH TRIANGLE PARK, N.C., U.S, and NANJING, China, Aug. 03, 2020 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, and ...
On Tuesday, police charged the driver with stunt driving and G1 licence offences. They didn’t provide the age or sex of the driver, who received a seven-day licence suspension and a 14-day vehicle ...
A driver has been charged with impaired operation by police in Toronto after she was stopped allegedly over the limit with a two-year-old in the car. In a post on social media, Ontario Provincial ...
- G1 to receive $6 million upfront payment, sales royalties and up to $40 million in future milestone payments- Genor to lead clinical development, regulatory submissions and commercialization of ...
Recently, I attended a local community meeting that, among other police-related topics, dealt with some neighbourhood traffic issues. At the end of the meeting, I was approached by a woman who seemed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback